semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Irritable Bowel Syndrome Presence of diarrhea predominant irritable bowel syndrome according to ROME  Gastrointestinal bleeding More than 5% weight loss in the last 6 months Presence of any finding in favor of organic disorders in the lab tests or organic disorder in colonoscopy of high risk patients
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 3.0-18.0,  Antibiotic Associated Diarrhea Clostridium Difficile Infection Gastroenteritis years of age Receiving antibiotics for not more than 48 hours prior to enrolment and free from diarrhoea The signed informed consent by one/both parents / legal guardian and by the subject if she/he is 12 years or older Available throughout the study period No use of any other probiotic products during the study period (Bulgarian yoghurt without added probiotics can be used) Subject or parents/guardian should have the mental ability to understand and willingness to fulfil all the details of the protocol  Three or more soft and unformed or watery stools per day at admission Receiving chemotherapy or radiation therapy Diagnosis of inflammatory bowel disease Enteral or parenteral nutrition only Requiring care in an intensive care unit Status post-bowel resection during hospitalization Receiving antibiotics four weeks prior to hospitalization Patient with severe life threatening illness or immunocompromised (HIV/AIDS, cancer, genetic disorders including cystic fibrosis, children with opportunistic infections, metabolic diseases) Pregnancy Lack of possibility to store the study product in a temperature below 25°C during the hot season of the year
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Colitis ICU patient positive c. diff PCR or visualization of pseudomembranes on colonoscopy able to give consent or have representative to give consent ability to drink contrast or have a previously placed nasogastric tube approval from the intensivist on duty/ICU Attending physician  Under age 18 pregnant need for gastric motility medications need for anti-diarrheal medication need for surgery previous small bowel or gastric surgery inability to drink nuclear tracer without nasogastric tube in place hypotension requiring vasoactive agents II score greater than 30
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Postoperative Pain Unilateral total knee replacement  Contra-indication for general anesthesia Infection on puncture site Coagulation disorders Pre-existent neuropathies Allergies to local anesthetics, paracetamol, diclofenac and tramadol Severe dyspepsia Less than 50kg weigh Body Mass Index (BMI) greater than 40 American Society of Anesthesiologists (ASA) Physical Status 4 or 5 Absence of capacity to use the Visual Analog Score (VAS) scale
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Infection patients with recurrent CDI that have failed standard therapy  critically ill patients
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Febrile Neutropenia adult neutropenic (< 500 cells) patients who are febrile  Patients with Creatinine Clearance < 30 ml/min or allergy to carbapenems will be excluded
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Diarrhea Clostridium Difficile non pregnant adults (≥18 years old) with a diagnosis of mild to severe CDAD (initial or recurrent) by positive C. difficile toxin assay along with clinical symptoms (watery stools, fever, abdominal pain). Patients will receive a minimum of 3 days of tigecycline  pregnant patients allergy to tetracycline (or tigecycline) antibiotics or patients with life-threatening illness
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cardiac Arrest Age at least 18 years or local age of consent Non-traumatic out-of-hospital cardiac arrest treated by Resuscitation Outcomes Consortium (ROC) emergency medical services (EMS) with advanced life support capability VF or pulseless VT presenting as the initial arrest arrhythmia or results from conversion of another arrhythmia (such as transient asystole or pulseless electrical activity) Incessant or recurrent VF/VT after receipt of ≥ 1 shocks Established vascular access  Asystole or pulseless electrical activity (PEA) as the initial arrest rhythm who never transition to VF or pulseless VT Written advance directive to not attempt resuscitation (DNAR) Blunt, penetrating, or burn-related injury Exsanguination Protected populations (prisoners, pregnancy, children under local age of consent) Treated exclusively by non-ROC EMS agency/provider, or by basic life support-only capable ROC EMS providers Prior receipt of open label lidocaine or amiodarone during resuscitation
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-21.0,  Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disorder Bacterial Meningitis Bacterial Septicemia Benzodiazepine Bipolar Disorder Bone and Joint Infections Central Nervous System Infections Convulsions Cytomegalovirus Retinitis Early-onset Schizophrenia Spectrum Disorders Epilepsy General Anesthesia Gynecologic Infections Herpes Simplex Virus Infantile Hemangioma Infection Inflammation Inflammatory Conditions Intra-abdominal Infections Lower Respiratory Tract Infections Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle Spasms Skin and Skin-structure Infections Treatment-resistant Schizophrenia Urinary Tract Infections Withdrawal Sepsis Gram-negative Infection Bradycardia Cardiac Arrest Cardiac Arrhythmia Staphylococcal Infections Nosocomial Pneumonia Neuromuscular Blockade Methicillin Resistant Staphylococcus Aureus Endocarditis Neutropenia Headache Fibrinolytic Bleeding Pulmonary Arterial Hypertension CMV Retinitis Hypertension Chronic Kidney Diseases Hyperaldosteronism Hypokalemia Heart Failure Hemophilia Heavy Menstrual Bleeding Insomnia Children (< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver  Failure to obtain consent/assent (as indicated) Known pregnancy as determined via interview or testing if available
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Pelvic Organ Prolapse Gynecologic Cancers Uterine Leiomyomata Adenomyosis Endometrial Hyperplasia Other Abnormal Uterine and Vaginal Bleeding Pelvic Mass Pelvic Pain age 18 or older plan to have one of the following types of surgery laparoscopic or abdominal gynecological surgery vaginal surgery able to provide written informed consent  under 18 years of age bilateral tubal ligation as the single reason for surgery current pregnancy unable to provide written informed consent
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 7.0-21.0,  C. Difficile Infection Aspirate at colonoscopy positive for C. diff Any gender Any race Age between 7-21 Greater than 21 kg Able to swallow pills  Abdominal tenderness and distention with minimal diarrhea History of inflammatory bowel disease Fever Systemic toxicity or allergy to metronidazole Short bowel syndrome History of bowel resection vii History of abdominal surgery (excluding appendectomy or cholecystectomy) History of hirschsprungs disease x Pregnant Inability to participate in phone surveys
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cognitive/Functional Effects Constipation, Impaction, and Bowel Obstruction Diarrhea Fatigue Gastrointestinal Complications Psychosocial Effects of Cancer and Its Treatment Unspecified Adult Solid Tumor, Protocol Specific Current diagnosis of cancer that supports the use of continuous definitive or adjuvant external-beam radiotherapy (RT) to the pelvis to a minimum dose of 4,500 cGy with the following parameters The pelvis must be encompassed by the planned RT fields The superior border may not lie inferior to the most inferior aspect of the sacroiliac joints Portions of the rectum may have special blocking, depending upon disease site The total prescription dose must lie between 4,500-5,350 cGy (inclusive) A boost to primary tumor or tumor bed may be planned Planned treatment is to be given 4-5 times per week on a one treatment-per-day basis The daily prescribed dose must lie between 170-210 cGy (inclusive) per day No planned split-course RT
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 30.0-75.0,  Uterine Myoma Persistent Post-menpausal Bleeding Uterine Cancer ASA 1-2 yrs Informed consent  Allergy to LA Chronic pain Major liver/kidney insufficiency AV Block 1-2 Participation in another clinical trial
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Intraventricular Hemorrhage Intracerebral Hemorrhage Hospitalization for an admitting diagnosis of hemorrhagic stroke admitted to the neurosurgical intensive care unit Age greater than 18 years No evidence of ischemic cerebrovascular injury  Concomitant traumatic brain injury Antibiotics on admission to the NICU Immunocompromised by chemotherapy or HIV positive or patient with neutropenia (ANC <1000) Women who are pregnant and/or of childbearing age where a pregnancy test has not already occurred
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Chronic Diarrhoea Lymphocytic Colitis Collagenous Colitis Patients with chronic non-bloody diarrhea for at least one month  Patients who decline to participate Unable to give informed consent
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 12.0-999.0,  Acute Upper Respiratory Tract Infection Has developed cold symptoms within 3 days prior to dosing on Day 1  Chronic illnesses. 2. Febrile illness > 101 F within 7 days prior to Day 1, 3. Pregnant. 4. Known current malignancy
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Irritable Bowel Syndrome Age 18 years or older 2. Subject meets Rome III for IBS (regardless of IBS subtype) as follows Recurrent abdominal pain or discomfort at least 3 days/month in the last 3 months associated with 2 or more of the following Improvement with defecation Onset associated with a change in frequency of stool Onset associated with a change in form (appearance) of stool Symptom onset must be at least 6 months prior to diagnosis 3. Agree to use contraception throughout study period, unless postmenopausal or surgically sterile (females only) 4. Able to understand the nature and purpose of the study including potential risks and side effects 5. Willing to consent to study participation and to comply with study requirements Abdominal pain or discomfort at least 2 days during run-in period associated with 2 or more of the following Improvement with defecation Onset associated with a change in frequency of stool Onset associated with a change in form (appearance) of stool  Diagnosed gastrointestinal disease, e.g. Crohn's disease, ulcer, cancer 2. Prior abdominal surgery that, in the investigator's opinion, may confound study outcomes 3. Any systemic disease that may confound IBS symptoms or compromise subject safety 4. Life expectancy < 6 months 5. Pregnant female or breastfeeding 6. Lactose intolerance 7. Immunodeficient subjects 8. Uncontrolled psychiatric disorder 9. Current treatment with nasogastric tube, ostomy, or parenteral nutrition 10. Eating disorder 11. Recent (< 2 weeks) antibiotic administration 12. History of alcohol, drug, or medication abuse 13. Daily consumption of probiotics, fermented milk, and/or yogurt 14. Known allergies to any substance in the study product 15. Participation in another study with any investigational product within 3 months of screening
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Associated Diarrhea Male and female patients 18 years of age or older 2. Mild to moderate C.difficile associated diarrhea (CDAD) with a positive stool C.difficile toxin (by ELISA). 3. Either a first episode of CDAD or a first recurrence (patients with more than 1 recurrence are not eligible) 4. Greater than 3 watery or unformed bowel movements in the prior 24 hours 5. Females of child bearing potential having a negative pregnancy test and taking adequate birth control measures. 6. Patients should not consume alcohol at least 12 hours prior to dosing (i.e. in-house monitoring) and until 48 hours after the last dose of drug administration (until Day 14). 7. Able to comprehend and give informed consent for the study and able to adhere to study schedules and protocol requirements  Known prior history of hypersensitivity to metronidazole or other nitroimidazole derivatives 2. Life expectancy ≤ 60 days 3. Sepsis, severe sepsis, or septic shock 4. Signs or symptoms of peritonitis, megacolon or ileus 5. History of ulcerative colitis or Crohn's disease 6. Oral or parenteral antibiotic therapy with metronidazole or vancomycin or other drugs effective in treating DCAD (e.g., bacitracin, fusidic acid) within the 1 week prior to enrollment 7. Recent history of significant drug or alcohol abuse within 1 year 8. Any findings on physical examination, medical history, 12-lead ECG or clinical laboratory tests which, in the judgment of the Principal Investigator, would patients from participating in the study 9. Patients with history of blood dyscrasias, porphyria and active non-infectious disease of the central nervous system 10. Patients with history of rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption 11. Pregnant or lactating female patients 12. Participation within 30 days before the start of this study in any experimental drug or device study, or currently participating in a study in which the administration of investigational drug or device within 60 days is anticipated 13. Unable to participate in the study for any reason in the opinion of the Principal Investigator